{"entity":{"type":"insider","cik":"0002048409","url":"/insider/0002048409","json_url":"/insider/0002048409.json","name":"Gallagher Kathleen P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2025-01-23","last":"2025-09-02","span_basis":"filed_date"},"name_variants":[{"name":"Gallagher Kathleen P.","source":"filing","n_filings":8,"first_seen":"2025-01-23","last_seen":"2025-09-02"}],"transactions":[{"id":4723563,"accession":"0001599901-25-000171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599901-25-000171","line_url":"/filing/0001599901-25-000171#line-1","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0002048409","owner_name":"Gallagher Kathleen P.","owner_display_name":"Gallagher Kathleen P.","owner_url":"/insider/0002048409","role":"Officer (Chief Program Officer)","role_mark":"O","role_mark_label":"Officer (Chief Program Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Program Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":188.0,"shares_display":"188","price_per_share":47.42,"price_display":"47.42","price_state":"stated","total_value":8914.96,"total_display":"8,914.96","total_whole":"8,915","shares_owned_after":50204.0,"shares_owned_after_display":"50,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-02","scope":"insider"},{"id":4046330,"accession":"0001599901-25-000131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599901-25-000131","line_url":"/filing/0001599901-25-000131#line-1","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0002048409","owner_name":"Gallagher Kathleen P.","owner_display_name":"Gallagher Kathleen P.","owner_url":"/insider/0002048409","role":"Officer (Chief Program Officer)","role_mark":"O","role_mark_label":"Officer (Chief Program Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Program Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":911.0,"shares_display":"911","price_per_share":30.24,"price_display":"30.24","price_state":"stated","total_value":27548.64,"total_display":"27,548.64","total_whole":"27,549","shares_owned_after":50392.0,"shares_owned_after_display":"50,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-17","filed_date":"2025-06-18","scope":"insider"},{"id":4534896,"accession":"0001599901-25-000109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-25-000109","line_url":"/filing/0001599901-25-000109#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0002048409","owner_name":"Gallagher Kathleen P.","owner_display_name":"Gallagher Kathleen P.","owner_url":"/insider/0002048409","role":"Officer (Chief Program Officer)","role_mark":"O","role_mark_label":"Officer (Chief Program Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Program Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5875.0,"shares_display":"5,875","price_per_share":32.4822,"price_display":"32.48","price_state":"stated","total_value":190832.925,"total_display":"190,832.92","total_whole":"190,833","shares_owned_after":50554.0,"shares_owned_after_display":"50,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-02","filed_date":"2025-06-04","scope":"insider"},{"id":4237973,"accession":"0001599901-25-000097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-25-000097","line_url":"/filing/0001599901-25-000097#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0002048409","owner_name":"Gallagher Kathleen P.","owner_display_name":"Gallagher Kathleen P.","owner_url":"/insider/0002048409","role":"Officer (Chief Program Officer)","role_mark":"O","role_mark_label":"Officer (Chief Program Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Program Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5875.0,"shares_display":"5,875","price_per_share":32.3956,"price_display":"32.40","price_state":"stated","total_value":190324.15,"total_display":"190,324.15","total_whole":"190,324","shares_owned_after":50554.0,"shares_owned_after_display":"50,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-02","scope":"insider"},{"id":4516028,"accession":"0001599901-25-000079","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001599901-25-000079","line_url":"/filing/0001599901-25-000079","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0002048409","owner_name":"Gallagher Kathleen P.","owner_display_name":"Gallagher Kathleen P.","owner_url":"/insider/0002048409","role":"Officer (Chief Program Officer)","role_mark":"O","role_mark_label":"Officer (Chief Program Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Program Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5875.0,"shares_display":"5,875","price_per_share":27.8274,"price_display":"27.83","price_state":"stated","total_value":163485.975,"total_display":"163,485.98","total_whole":"163,486","shares_owned_after":50554.0,"shares_owned_after_display":"50,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-03","scope":"insider","n_lines":2},{"id":4032457,"accession":"0001599901-25-000061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-25-000061","line_url":"/filing/0001599901-25-000061#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0002048409","owner_name":"Gallagher Kathleen P.","owner_display_name":"Gallagher Kathleen P.","owner_url":"/insider/0002048409","role":"Officer (Chief Program Officer)","role_mark":"O","role_mark_label":"Officer (Chief Program Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Program Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5875.0,"shares_display":"5,875","price_per_share":29.414,"price_display":"29.41","price_state":"stated","total_value":172807.25,"total_display":"172,807.25","total_whole":"172,807","shares_owned_after":50554.0,"shares_owned_after_display":"50,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":4723530,"accession":"0001599901-25-000045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-25-000045","line_url":"/filing/0001599901-25-000045#line-2","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0002048409","owner_name":"Gallagher Kathleen P.","owner_display_name":"Gallagher Kathleen P.","owner_url":"/insider/0002048409","role":"Officer (Chief Program Officer)","role_mark":"O","role_mark_label":"Officer (Chief Program Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Program Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5875.0,"shares_display":"5,875","price_per_share":32.1563,"price_display":"32.16","price_state":"stated","total_value":188918.2625,"total_display":"188,918.26","total_whole":"188,918","shares_owned_after":50554.0,"shares_owned_after_display":"50,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-05","scope":"insider"},{"id":4032453,"accession":"0001599901-25-000033","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001599901-25-000033","line_url":"/filing/0001599901-25-000033#line-4","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0002048409","owner_name":"Gallagher Kathleen P.","owner_display_name":"Gallagher Kathleen P.","owner_url":"/insider/0002048409","role":"Officer (Chief Program Officer)","role_mark":"O","role_mark_label":"Officer (Chief Program Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Program Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5629.0,"shares_display":"5,629","price_per_share":30.1609,"price_display":"30.16","price_state":"stated","total_value":169775.7061,"total_display":"169,775.71","total_whole":"169,776","shares_owned_after":50554.0,"shares_owned_after_display":"50,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-23","scope":"insider"},{"id":4032452,"accession":"0001599901-25-000033","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001599901-25-000033","line_url":"/filing/0001599901-25-000033","is_derivative":false,"issuer_cik":"0001599901","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001599901","owner_cik":"0002048409","owner_name":"Gallagher Kathleen P.","owner_display_name":"Gallagher Kathleen P.","owner_url":"/insider/0002048409","role":"Officer (Chief Program Officer)","role_mark":"O","role_mark_label":"Officer (Chief Program Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Program Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3782.0,"shares_display":"3,782","price_per_share":28.592380222104705,"price_display":"28.59","price_state":"stated","total_value":108136.382,"total_display":"108,136.38","total_whole":"108,136","shares_owned_after":56183.0,"shares_owned_after_display":"56,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001599901","name":"Avidity Biosciences, Inc.","url":"/issuer/0001599901","role":"Officer (Chief Program Officer)","n_filings":8,"first_seen":"2025-01-23","last_seen":"2025-09-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002048409","retrieved_at":"2026-08-22T07:25:24+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}